SH3PXD2A and cancer: In cancer, the expression level of Tks5α or the ratio of Tks5α expression to Tks5β/Tks5short expression, rather than the total level of Tks5, is correlated to poor prognosis and lower metastasis-free survival in diverse cancer types15,17–20.